JUN 3, 2026 · JOURNAL ARTICLE
Targeted pneumococcal conjugate vaccination strategies for high-risk children.
Human Vaccines & Immunotherapeutics
This mini-review synthesizes evidence on disease burden and immune vulnerability in high-risk child populations to inform targeted PCV strategies, but contains no new primary data or comparative trials.
Reported
Pneumococcal contribution to chil…28% of approximately 500,000 deaths
Mortality risk ratio: moderately…2
Mortality risk ratio: severely un…5